Lymphokine-Activated Killer Cells or Gliadel Wafer in Treating Patients With Newly Diagnosed Glioblastoma Multiforme That Can Be Removed by Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00814593
Recruitment Status : Terminated (Hoag Hospital ceased support.)
First Posted : December 25, 2008
Last Update Posted : July 2, 2014
Information provided by (Responsible Party):
Caladrius Biosciences, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : April 2011
  Actual Study Completion Date : September 2011